# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-16-670098
Filing Date
2016-08-03
Accepted
2016-08-03 16:14:14
Documents
39
Period of Report
2016-08-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d230511d8k.htm | 8-K | 25363
2 | EX-99.1 | d230511dex991.htm | EX-99.1 | 22098
3 | EX-99.2 | d230511dex992.htm | EX-99.2 | 25720
4 | GRAPHIC | g230511ex99_2s10g1.jpg | GRAPHIC | 276780
5 | GRAPHIC | g230511ex99_2s11g1.jpg | GRAPHIC | 292774
6 | GRAPHIC | g230511ex99_2s12g1.jpg | GRAPHIC | 187429
7 | GRAPHIC | g230511ex99_2s13g1.jpg | GRAPHIC | 247865
8 | GRAPHIC | g230511ex99_2s14g1.jpg | GRAPHIC | 200409
9 | GRAPHIC | g230511ex99_2s15g1.jpg | GRAPHIC | 311121
10 | GRAPHIC | g230511ex99_2s16g1.jpg | GRAPHIC | 262909
11 | GRAPHIC | g230511ex99_2s17g1.jpg | GRAPHIC | 209093
12 | GRAPHIC | g230511ex99_2s18g1.jpg | GRAPHIC | 197926
13 | GRAPHIC | g230511ex99_2s19g1.jpg | GRAPHIC | 275495
14 | GRAPHIC | g230511ex99_2s1g1.jpg | GRAPHIC | 146148
15 | GRAPHIC | g230511ex99_2s20g1.jpg | GRAPHIC | 193336
16 | GRAPHIC | g230511ex99_2s21g1.jpg | GRAPHIC | 247109
17 | GRAPHIC | g230511ex99_2s22g1.jpg | GRAPHIC | 223155
18 | GRAPHIC | g230511ex99_2s23g1.jpg | GRAPHIC | 239610
19 | GRAPHIC | g230511ex99_2s24g1.jpg | GRAPHIC | 179226
20 | GRAPHIC | g230511ex99_2s25g1.jpg | GRAPHIC | 190643
21 | GRAPHIC | g230511ex99_2s26g1.jpg | GRAPHIC | 155284
22 | GRAPHIC | g230511ex99_2s27g1.jpg | GRAPHIC | 279713
23 | GRAPHIC | g230511ex99_2s28g1.jpg | GRAPHIC | 296212
24 | GRAPHIC | g230511ex99_2s29g1.jpg | GRAPHIC | 202148
25 | GRAPHIC | g230511ex99_2s2g1.jpg | GRAPHIC | 292881
26 | GRAPHIC | g230511ex99_2s30g1.jpg | GRAPHIC | 187408
27 | GRAPHIC | g230511ex99_2s31g1.jpg | GRAPHIC | 282823
28 | GRAPHIC | g230511ex99_2s32g1.jpg | GRAPHIC | 260442
29 | GRAPHIC | g230511ex99_2s33g1.jpg | GRAPHIC | 218304
30 | GRAPHIC | g230511ex99_2s34g1.jpg | GRAPHIC | 349836
31 | GRAPHIC | g230511ex99_2s35g1.jpg | GRAPHIC | 337490
32 | GRAPHIC | g230511ex99_2s3g1.jpg | GRAPHIC | 337458
33 | GRAPHIC | g230511ex99_2s4g1.jpg | GRAPHIC | 268632
34 | GRAPHIC | g230511ex99_2s5g1.jpg | GRAPHIC | 177783
35 | GRAPHIC | g230511ex99_2s6g1.jpg | GRAPHIC | 201900
36 | GRAPHIC | g230511ex99_2s7g1.jpg | GRAPHIC | 273700
37 | GRAPHIC | g230511ex99_2s8g1.jpg | GRAPHIC | 196115
38 | GRAPHIC | g230511ex99_2s9g1.jpg | GRAPHIC | 259272
39 | GRAPHIC | g230511g0803200800051.jpg | GRAPHIC | 3815
| Complete submission text file | 0001193125-16-670098.txt |  | 11734354

Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 161804003
SIC: 2835 In Vitro & In Vivo Diagnostic Substances